Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2021 Dec 5;21(1):275.
doi: 10.1186/s12874-021-01459-8.

Communicating incidental and reportable findings from research MRIs: considering factors beyond the findings in an underrepresented pediatric population

Affiliations
Randomized Controlled Trial

Communicating incidental and reportable findings from research MRIs: considering factors beyond the findings in an underrepresented pediatric population

Kiley B Vander Wyst et al. BMC Med Res Methodol. .

Abstract

Background: The application of advanced imaging in pediatric research trials introduces the challenge of how to effectively handle and communicate incidental and reportable findings. This challenge is amplified in underserved populations that experience disparities in access to healthcare as recommendations for follow-up care may be difficult to coordinate. Therefore, the purpose of the present report is to describe the process for identifying and communicating findings from a research MRI to low-income Latino children and families.

Methods: Latino adolescents (n = 86) aged 12-16 years old with obesity and prediabetes underwent a research MRI (3 Tesla Philips Ingenia®) as part of a randomized controlled diabetes prevention trial. The research MRIs were performed at baseline and 6 months to assess changes in whole-abdominal fat distribution and organ fat in response to the intervention. An institutional pathway was developed for identifying and reporting findings to participants and families. The pathway was developed through a collaborative process with hospital administration, research compliance, radiology, and the research team. All research images were reviewed by a board-certified pediatric radiologist who conveyed findings to the study pediatrician for determination of clinical actionability and reportability to children and families. Pediatric sub-specialists were consulted as necessary and a primary care practitioner (PCP) from a free community health clinic agreed to receive referrals for uninsured participants.

Results: A total of 139 images (86 pre- and 53 post-intervention) were reviewed with 31 findings identified and 23 deemed clinically actionable and reportable. The only reportable finding was severely elevated liver fat (> 10%, n = 14) with the most common and concerning incidental findings being horseshoe kidney (n = 1) and lung lesion (n = 1). The remainder (n = 7) were less serious. Of youth with a reportable or incidental finding, 18 had a PCP but only 7 scheduled a follow-up appointment. Seven participants without a PCP were referred to a safety-net clinic for follow-up.

Conclusions: With the increased utilization of high-resolution imaging in pediatric research, additional standardization is needed on what, when, and how to return incidental and reportable findings to participants, particularly among historically underrepresented populations that may be underserved in the community.

Trial registration: Preventing Diabetes in Latino Youth, NCT02615353.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Preventing Diabetes in Latino Youth CONSORT Flow Diagram
Fig. 2
Fig. 2
Timeline of Major Events Leading to Development of an Institutional Pathway
Fig. 3
Fig. 3
Institutional Pathway for Identification and Reporting Incidental (IFs) and Reportable Findings

References

    1. Wong CA, Hernandez AF, Califf RM. Return of research results to study participants uncharted and untested. JAMA. 2018;320:435–436. doi: 10.1001/jama.2018.7898. - DOI - PubMed
    1. Office for Human Research Protections. Attachment F - Recommendations on Reporting Incidental Findings.
    1. Presidential Commission for the Study of Bioethical Issues. ANTICIPATE and COMMUNICATE: Ethical Management of Incidental and Secondary Findings in the Clinical , Research , and Direct-to-Consumer Contexts. Washington, D.C.; 2013. - PubMed
    1. Li Y, Thompson WK, Reuter C, Nillo R, Jernigan T, Dale A, et al. Rates of incidental findings in brain magnetic resonance imaging in children. JAMA Neurol. 2021;78:578–587. doi: 10.1001/jamaneurol.2021.0306. - DOI - PMC - PubMed
    1. Meacham MC, Starks H, Burke W, Edwards K. Researcher perspectives on disclosure of incidental findings in genetic research. J Empir Res Hum Res Ethics. 2010;5:31–41. doi: 10.1525/jer.2010.5.3.31. - DOI - PMC - PubMed

Publication types

Associated data